View in EDS HTML Full Text PDF Full Text

Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.

Saved in:
Bibliographic Details
Title: Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Authors: Proteau S; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Krossa I; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Husser C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Guéguinou M; University of Tours, Tours, France.; Inserm, N2C UMR 1069, Tours, France., Sella F; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Bille K; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Irondelle M; University Côte d'Azur, Nice, France., Dalmasso M; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Barouillet T; Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular Medicine, Nice, France., Cheli Y; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Pisibon C; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Arrighi N; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Nahon-Estève S; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France., Martel A; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France., Gastaud L; Centre Antoine Lacassagne, Nice, France., Lassalle S; University Côte d'Azur, Nice, France.; Laboratory of Clinical and Experimental Pathology, University Hospital of Nice, FHU OncoAge, Cote d'Azur University, Biobank BB-0033-00025, IRCAN team 4, OncoAge FHU, Nice, France., Mignen O; LBAI, UMR1227, Univ Brest, Inserm, Brest, France., Brest P; University Côte d'Azur, Nice, France.; IRCAN team 4, Inserm, CNRS, FHU-oncoAge, IHU-RESPIRera, Nice, France., Mazure NM; University Côte d'Azur, Nice, France.; Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Bost F; University Côte d'Azur, Nice, France.; Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Baillif S; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France., Landreville S; Département d'ophtalmologie et d'ORL-CCF, Faculté de médecine, Université Laval, Quebec City, QC, Canada.; CUO-Recherche and Axe médecine régénératrice, Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.; Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC, Canada.; Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC, Canada., Turcotte S; Cancer Axis, Centre de recherche du Centre Hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Montréal, QC, Canada.; Hepato-Pancreato-Biliary Surgery and Liver Transplantation Service, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada., Hasson D; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Carcamo S; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Vandier C; University of Tours, Tours, France.; Inserm, N2C UMR 1069, Tours, France., Bernstein E; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Yvan-Charvet L; University Côte d'Azur, Nice, France.; Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular Medicine, Nice, France., Levesque MP; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Ballotti R; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France., Bertolotto C; University Côte d'Azur, Nice, France. Corine.Bertolotto@univ-cotedazur.fr.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France. Corine.Bertolotto@univ-cotedazur.fr., Strub T; University Côte d'Azur, Nice, France. thomas.strub@univ-cotedazur.fr.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France. thomas.strub@univ-cotedazur.fr.
Source: EMBO molecular medicine [EMBO Mol Med] 2024 Sep; Vol. 16 (9), pp. 2262-2267.
Publication Type: Published Erratum
Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39164473
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Proteau+S%22">Proteau S</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Krossa+I%22">Krossa I</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Husser+C%22">Husser C</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Guéguinou+M%22">Guéguinou M</searchLink>; University of Tours, Tours, France.; Inserm, N2C UMR 1069, Tours, France.<br /><searchLink fieldCode="AU" term="%22Sella+F%22">Sella F</searchLink>; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bille+K%22">Bille K</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Irondelle+M%22">Irondelle M</searchLink>; University Côte d'Azur, Nice, France.<br /><searchLink fieldCode="AU" term="%22Dalmasso+M%22">Dalmasso M</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Barouillet+T%22">Barouillet T</searchLink>; Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Cheli+Y%22">Cheli Y</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Pisibon+C%22">Pisibon C</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Arrighi+N%22">Arrighi N</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Nahon-Estève+S%22">Nahon-Estève S</searchLink>; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France.<br /><searchLink fieldCode="AU" term="%22Martel+A%22">Martel A</searchLink>; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France.<br /><searchLink fieldCode="AU" term="%22Gastaud+L%22">Gastaud L</searchLink>; Centre Antoine Lacassagne, Nice, France.<br /><searchLink fieldCode="AU" term="%22Lassalle+S%22">Lassalle S</searchLink>; University Côte d'Azur, Nice, France.; Laboratory of Clinical and Experimental Pathology, University Hospital of Nice, FHU OncoAge, Cote d'Azur University, Biobank BB-0033-00025, IRCAN team 4, OncoAge FHU, Nice, France.<br /><searchLink fieldCode="AU" term="%22Mignen+O%22">Mignen O</searchLink>; LBAI, UMR1227, Univ Brest, Inserm, Brest, France.<br /><searchLink fieldCode="AU" term="%22Brest+P%22">Brest P</searchLink>; University Côte d'Azur, Nice, France.; IRCAN team 4, Inserm, CNRS, FHU-oncoAge, IHU-RESPIRera, Nice, France.<br /><searchLink fieldCode="AU" term="%22Mazure+NM%22">Mazure NM</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Bost+F%22">Bost F</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Baillif+S%22">Baillif S</searchLink>; University Côte d'Azur, Nice, France.; Centre Hospitalier Universitaire of Nice, Department of Ophthalmology, Nice, France.<br /><searchLink fieldCode="AU" term="%22Landreville+S%22">Landreville S</searchLink>; Département d'ophtalmologie et d'ORL-CCF, Faculté de médecine, Université Laval, Quebec City, QC, Canada.; CUO-Recherche and Axe médecine régénératrice, Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.; Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC, Canada.; Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Turcotte+S%22">Turcotte S</searchLink>; Cancer Axis, Centre de recherche du Centre Hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Montréal, QC, Canada.; Hepato-Pancreato-Biliary Surgery and Liver Transplantation Service, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Hasson+D%22">Hasson D</searchLink>; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Carcamo+S%22">Carcamo S</searchLink>; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Facility, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Vandier+C%22">Vandier C</searchLink>; University of Tours, Tours, France.; Inserm, N2C UMR 1069, Tours, France.<br /><searchLink fieldCode="AU" term="%22Bernstein+E%22">Bernstein E</searchLink>; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.<br /><searchLink fieldCode="AU" term="%22Yvan-Charvet+L%22">Yvan-Charvet L</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Levesque+MP%22">Levesque MP</searchLink>; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ballotti+R%22">Ballotti R</searchLink>; University Côte d'Azur, Nice, France.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France.<br /><searchLink fieldCode="AU" term="%22Bertolotto+C%22">Bertolotto C</searchLink>; University Côte d'Azur, Nice, France. Corine.Bertolotto@univ-cotedazur.fr.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France. Corine.Bertolotto@univ-cotedazur.fr.<br /><searchLink fieldCode="AU" term="%22Strub+T%22">Strub T</searchLink>; University Côte d'Azur, Nice, France. thomas.strub@univ-cotedazur.fr.; Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular Medicine, Nice, France. thomas.strub@univ-cotedazur.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101487380%22">EMBO molecular medicine</searchLink> [EMBO Mol Med] 2024 Sep; Vol. 16 (9), pp. 2262-2267.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22EMBO+Press%22">EMBO Press </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101487380 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1757-4684 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217574676%22">17574676 </searchLink><i>NLM ISO Abbreviation: </i>EMBO Mol Med <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39164473
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s44321-024-00114-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2262
    Titles:
      – TitleFull: Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Proteau S
      – PersonEntity:
          Name:
            NameFull: Krossa I
      – PersonEntity:
          Name:
            NameFull: Husser C
      – PersonEntity:
          Name:
            NameFull: Guéguinou M
      – PersonEntity:
          Name:
            NameFull: Sella F
      – PersonEntity:
          Name:
            NameFull: Bille K
      – PersonEntity:
          Name:
            NameFull: Irondelle M
      – PersonEntity:
          Name:
            NameFull: Dalmasso M
      – PersonEntity:
          Name:
            NameFull: Barouillet T
      – PersonEntity:
          Name:
            NameFull: Cheli Y
      – PersonEntity:
          Name:
            NameFull: Pisibon C
      – PersonEntity:
          Name:
            NameFull: Arrighi N
      – PersonEntity:
          Name:
            NameFull: Nahon-Estève S
      – PersonEntity:
          Name:
            NameFull: Martel A
      – PersonEntity:
          Name:
            NameFull: Gastaud L
      – PersonEntity:
          Name:
            NameFull: Lassalle S
      – PersonEntity:
          Name:
            NameFull: Mignen O
      – PersonEntity:
          Name:
            NameFull: Brest P
      – PersonEntity:
          Name:
            NameFull: Mazure NM
      – PersonEntity:
          Name:
            NameFull: Bost F
      – PersonEntity:
          Name:
            NameFull: Baillif S
      – PersonEntity:
          Name:
            NameFull: Landreville S
      – PersonEntity:
          Name:
            NameFull: Turcotte S
      – PersonEntity:
          Name:
            NameFull: Hasson D
      – PersonEntity:
          Name:
            NameFull: Carcamo S
      – PersonEntity:
          Name:
            NameFull: Vandier C
      – PersonEntity:
          Name:
            NameFull: Bernstein E
      – PersonEntity:
          Name:
            NameFull: Yvan-Charvet L
      – PersonEntity:
          Name:
            NameFull: Levesque MP
      – PersonEntity:
          Name:
            NameFull: Ballotti R
      – PersonEntity:
          Name:
            NameFull: Bertolotto C
      – PersonEntity:
          Name:
            NameFull: Strub T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1757-4684
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: EMBO molecular medicine
              Type: main
ResultId 1